Light Science Technologies CEO on expanding into healthcare market with CEM contract

About this episode

Light Science Technologies CEO Simon Deacon discusses the company's expansion into the healthcare market with a significant contract and its growth strategy.

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon tells Proactive's Stephen Gunnion that the company has landed a healthcare contract worth more than £600,000 annually with an international blue-chip client — a significant step in its push into higher-margin markets. "We see healthcare, defence and medical as being the higher margin markets," Deacon says, outlining a deliberate shift away from customer concentration in pest control toward sectors that offer better returns and larger international partners. The contract electronics manufacturing division is also playing a broader role within the group, supporting AgTech product manufacturing and creating new opportunities following the Injectaclad acquisition — positioning Light Science as an increasingly integrated business rather than a collection of separate divisions. Watch the full interview to hear more about Light Science Technologies’ growth strategy, international opportunities and focus on improving margins across its divisions. For more videos like this, visit the Proactive YouTube channel, give this video a like, subscribe to the channel and enable notifications so you never miss future…

People in this episode

Host: Stephen Gunnion

Guest: Simon Deacon

Topics covered

• healthcare market
• electronics manufacturing
• business growth
• international opportunities
• higher-margin markets

Keywords

• Light Science Technologies
• healthcare contract
• electronics manufacturing
• AgTech
• business growth
• international partners
• higher margins
• defense sector
• medical technology

Mentioned in this episode

Organizations: Light Science Technologies Holdings PLC, CEM, AgTech, Injectaclad, Proactive

Places: UK

More episodes of Proactive - Interviews for investors

• Regan Capital CIO on bond market opportunities in a rising rate environment · June 12, 2026 · 6 min
• Light Science Technologies lifts capacity 50% with new SMT line and global client win · June 12, 2026 · 5 min
• Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects · June 12, 2026 · 4 min
• Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver · June 11, 2026 · 8 min
• Flow Metals advances drill-ready Yukon gold project while expanding Copper exploration in B.C. · June 11, 2026 · 6 min
• Midstream energy sector positioned for growth as LNG and AI drive demand · June 11, 2026 · 7 min